CRIS Current Research Information System

STAGNI, FIORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.943
AS - Asia 2.805
EU - Europa 1.904
AF - Africa 211
SA - Sud America 123
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.885
SG - Singapore 864
IT - Italia 772
VN - Vietnam 731
CN - Cina 638
GB - Regno Unito 272
DE - Germania 225
HK - Hong Kong 163
SE - Svezia 119
FR - Francia 93
IN - India 91
NL - Olanda 88
BR - Brasile 85
BD - Bangladesh 81
CI - Costa d'Avorio 62
TG - Togo 58
IE - Irlanda 56
KR - Corea 56
RU - Federazione Russa 51
JP - Giappone 48
ZA - Sudafrica 46
FI - Finlandia 43
PH - Filippine 30
CA - Canada 28
BG - Bulgaria 27
CH - Svizzera 25
JO - Giordania 23
BE - Belgio 22
UA - Ucraina 21
SC - Seychelles 19
AR - Argentina 18
TH - Thailandia 18
AT - Austria 17
EE - Estonia 16
MX - Messico 15
ES - Italia 10
PL - Polonia 10
GR - Grecia 9
ID - Indonesia 9
TR - Turchia 9
IQ - Iraq 8
LT - Lituania 8
NG - Nigeria 7
SA - Arabia Saudita 6
TW - Taiwan 6
AU - Australia 5
EC - Ecuador 5
JM - Giamaica 5
CL - Cile 4
IR - Iran 4
KE - Kenya 4
MY - Malesia 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DZ - Algeria 3
ET - Etiopia 3
HR - Croazia 3
RO - Romania 3
UY - Uruguay 3
AL - Albania 2
CR - Costa Rica 2
HU - Ungheria 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SD - Sudan 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.992
Salva come PNG Salva come JPEG
Città #
Singapore 601
Ashburn 317
Bologna 262
Chandler 258
Fairfield 237
Southend 231
Hanoi 180
Ho Chi Minh City 176
San Jose 156
Hong Kong 146
Santa Clara 142
Houston 130
Hefei 122
Seattle 115
Wilmington 114
Ann Arbor 107
Woodbridge 96
Beijing 78
Cambridge 68
Abidjan 62
Council Bluffs 60
Princeton 60
Frankfurt am Main 58
Lomé 58
Boardman 57
Dublin 56
Los Angeles 52
New York 48
Dong Ket 47
Seoul 42
Turin 42
Lauterbourg 37
Milan 37
Tokyo 35
Dallas 34
Redmond 33
Buffalo 32
Helsinki 32
Rimini 30
Rome 30
Falls Church 29
Sofia 27
Johannesburg 25
Da Nang 24
Amman 23
Haiphong 23
Bern 21
Brussels 21
Munich 21
Westminster 21
Nanjing 19
Chicago 17
Shanghai 17
Padova 16
Guangzhou 15
Jinan 15
San Diego 15
Shenyang 15
Tianjin 15
Amsterdam 14
Berlin 14
Bengaluru 13
Vienna 12
Hải Dương 11
London 11
Redondo Beach 11
Trento 11
Bolzano 10
Florence 10
Redwood City 10
Saint Petersburg 10
Toronto 10
Changsha 9
Ha Long 9
Hebei 9
Naples 9
Orem 9
Phoenix 9
São Paulo 9
Udine 9
Wuhan 9
Zhengzhou 9
Des Moines 8
Meldola 8
Mexico City 8
Philadelphia 8
Bangkok 7
Bắc Ninh 7
Nanchang 7
Ninh Bình 7
Palermo 7
San Francisco 7
Vũng Tàu 7
Biên Hòa 6
Jakarta 6
Lappeenranta 6
Manila 6
Olalla 6
Paris 6
Portsmouth 6
Totale 5.217
Salva come PNG Salva come JPEG
Nome #
Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome 310
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 308
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders 274
Impaired brain mitochondrial bioenergetics in the ts65dn mouse model of down syndrome is restored by neonatal treatment with the polyphenol 7,8-dihydroxyflavone 258
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 255
Obstructive sleep apneas naturally occur in mice during REM sleep and are highly prevalent in a mouse model of Down syndrome 240
Abnormal development of the inferior temporal region in fetuses with Down Syndrome 238
Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome 229
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 227
Early appearance of dendritic alterations in neocortical pyramidal neurons of the Ts65Dn model of Down syndrome 221
Effect of adolescent treatment with the flavonoid 7,8-DHF on brain wiring, synaptic plasticity and cognitive performance in a model of Down syndrome 220
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 220
Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome? 218
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 215
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 213
Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome 205
Neuroanatomical Alterations in Higher-Order Thalamic Nuclei of Fetuses With Down Syndrome 205
Increased hippocampal epigenetic age in the Ts65Dn mouse model of Down Syndrome 197
SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation 188
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 185
The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome 183
Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome. 182
Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model 181
Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome 181
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome 170
Timing of therapies for downsyndrome: The sooner, the better 166
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. 162
Cellularity Defects Are Not Ubiquitous in the Brains of Fetuses With Down Syndrome 157
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. 157
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 155
Dendritic phenotype and proliferation potency in the hippocampal dentate gyrus of the Ts66Yah model of Down syndrome 138
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives 135
Targeting APP/AICD in Down syndrome 131
null 130
Neurogenesis impairment: An early developmental defect in Down syndrome 127
Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus, and Down syndrome 120
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 102
null 97
Advocating for increased awareness and research on Down syndrome 95
null 83
“Analisi dell’espressione genica in ippocampi di topi Ts65Dn sottoposti a trattamento adolescenziale con il BDNF-mimetico 7,8 diidrossiflavone” 75
“Administration of the BDNF mimetic 7,8-Dihydroxyflavone during adolescence rescues neuron maturation and improves hippocampus- dependent memory in the Ts65Dn mouse model of Down syndrome”. 70
“Il trattamento adolescenziale con il BDNF mimetico 7,8-diidrossiflavone influenza la metilazione del DNA nell'ippocampo del modello Ts65Dn di sindrome di Down” 63
“Effects of 7,8-dihydroxyflavone treatment on DNA methylation profiles of adolescent Ts65Dn mice hippocampus” 59
“Trattamento adolescenziale con il BDNF mimetico 7,8- diidrossiflavone: una strategia utile per migliorare lo sviluppo della fascia dentata ippocampica nel modello Ts65Dn di sindrome di Down”. 56
“Adolescence represents an important window of opportunity for the rescue of dendritic pathology with a BDNF mimetic in a mouse model of Down syndrome” 52
“Early pharmacotherapies for the rescue of intellectual disability in Down syndrome” 52
“Trattamento neonatale con astaxantina veicolata tramite nanoparticelle: effetti sullo sviluppo ippocampale e sullo stress ossidativo nel modello murino Ts65D” 51
“Is it possible to prevent or counteract Alzheimer’s disease in Down syndrome with molecules with antioxidant and anti-inflammatory properties?” 50
“Il trattamento con il polifenolo Polidatina migliora lo sviluppo cerebrale e la memoria ippocampo-dipendente nel topo Ts65Dn, modello di sindrome di Down” 48
“La somministrazione neonatale di astaxantina tramite nanoparticelle ha un effetto proproliferativo nel modello murino Ts65Dn” 47
“Effects of neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles on hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome” 46
“Neonatal treatment with astaxanthin-loaded stealth lipid nanoparticles fosters hippocampal neurogenesis in a mouse model of Down syndrome” 42
Totale 8.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.096
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022584 33 27 25 15 68 42 55 35 26 37 110 111
2022/2023960 74 161 52 121 62 77 37 57 147 15 79 78
2023/2024284 21 46 17 29 15 55 3 5 3 21 41 28
2024/20251.218 76 88 98 85 179 50 131 66 37 96 106 206
2025/20263.475 311 223 203 237 340 288 307 168 761 281 223 133
2026/2027127 127 0 0 0 0 0 0 0 0 0 0 0
Totale 8.189